| Name | Cambridge Cognition Holdings |
|---|---|
| Epic | COG |
| Isin | GB00B8DV9647 |
| Industry | Medical Equipment and Services |
| Latest share price | 34.00p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £15.85 | Debt ratio | n/a |
| Shares in issue | 46.63 | Debt-to-equity ratio | n/a |
| P/E ratio | n/a | Assets / equity ratio | n/a |
| Total dividends per share | n/a | Price to book value | n/a |
| Dividend yield | n/a | ROCE | 74.56 |
| Dividend cover | n/a | EPS growth | n/a |
| Earning per share | -4.6 | 52-week high / low | 25.00p / 46.00p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| No dividends declared | |||
| Company name | Cambridge Cognition Holdings |
|---|---|
| Address | Tunbridge Court,Tunbridge Lane,Bottisham Cambridge,United Kingdom, CB25 9TU |
| Telephone | +44 (0)1223 810700 |
| Website | http://www.cambridgecognition.com/ |
| Director | Position |
|---|---|
| Dr Steven John Powell | Chairman |
| Mr Debra Leeves | Non-Executive Director |
| Mr Richard Bungay | Non-Executive Director |
| Mr Stuart Gall | Independent Non-Executive Director |
| Mr Nick (Philip) Rodgers | Independent Non-Executive Director |
| Mr Jon Kempster | Independent Non-Executive Director |
| Mr Bob Baker | Group COO |
| Assets £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Reporting date | 31/12/24 | 31/12/23 | 31/12/22 |
| Intangible asssets and goodwill | 6.79 | 7.74 | 1.42 |
| Investments and other non-current assets | 1.84 | 0.16 | 0.05 |
| Total non-current assets | 8.69 | 8.05 | 1.66 |
| Inventory / work in progress | 0.13 | 0.19 | 0.22 |
| Trade and other receivables | 2.63 | 2.42 | 4.91 |
| Cash and equivalents | 1.29 | 3.22 | 8.32 |
| Other current assets and asset held for resale | 0.29 | 0.35 | n/a |
| Total of all assets | 13.03 | 14.23 | 15.11 |
| Liabilities £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Short term liabilities | 8.76 | 10.97 | 15.01 |
| Long term liabilities | 0.9 | 1.98 | n/a |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 9.67 | 12.95 | 15.01 |
| Net assets £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net assets | 3.36 | 1.28 | 0.1 |
| Equity £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Share capital | 0.42 | 0.35 | 0.31 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | -19.83 | -19.78 | -17.12 |
| Share premium account | 17.64 | 15.17 | 11.15 |
| Total equity | 3.36 | 1.28 | 0.1 |
| Income £ (m) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | -1.14 | -3.31 | -0.62 |
| Pre-tax profit | -1.71 | -3.46 | -0.62 |